[1]
2024. Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s471. DOI:https://doi.org/10.25251/skin.8.supp.471.